Zhu B - Search Results

1

Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks.

Marzo-Ortega H, Mease PJ, Rahman P, Navarro-Compán V, Strand V, Dougados M, Combe B, Wei JC, Baraliakos X, Hunter T, Sandoval D, Li X, Zhu B, Bessette L, Deodhar A. Marzo-Ortega H, et al. Among authors: zhu b. Rheumatol Ther. 2020 Dec;7(4):759-774. doi: 10.1007/s40744-020-00225-4. Epub 2020 Aug 19. Rheumatol Ther. 2020. PMID: 32814997 Free PMC article.

2

Relationship between disease activity and patient-reported outcomes in rheumatoid arthritis: Post hoc analyses of overall and Japanese results from two phase 3 clinical trials.

Ishiguro N, Dougados M, Cai Z, Zhu B, Ishida M, Sato M, Gaich C, Quebe A, Stoykov I, Tanaka Y. Ishiguro N, et al. Among authors: zhu b. Mod Rheumatol. 2018 Nov;28(6):950-959. doi: 10.1080/14397595.2017.1422232. Epub 2018 Feb 2. Mod Rheumatol. 2018. PMID: 29278006

3

Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial.

Michaud K, Pope JE, Emery P, Zhu B, Gaich CL, DeLozier AM, Zhang X, Dickson CL, Smolen JS. Michaud K, et al. Among authors: zhu b. Rheumatol Ther. 2019 Sep;6(3):409-419. doi: 10.1007/s40744-019-0164-4. Epub 2019 Jun 21. Rheumatol Ther. 2019. PMID: 31228100 Free PMC article.

4

Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis.

Langley RGB, Reich K, Strand V, Feldman SR, Paul C, Gordon K, Warren RB, Toth D, Nikaï E, Zhu B, Goldblum O, Edson-Heredia E, Carlier H, Burge R, Lin CY, Hollister K, Augustin M. Langley RGB, et al. Among authors: zhu b. Qual Life Res. 2020 Feb;29(2):369-380. doi: 10.1007/s11136-019-02296-5. Epub 2019 Oct 26. Qual Life Res. 2020. PMID: 31655974 Clinical Trial.

5

Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial.

Walsh JA, Magrey MN, Baraliakos X, Inui K, Weng MY, Lubrano E, van der Heijde D, Boonen A, Gensler LS, Strand V, Braun J, Hunter T, Li X, Zhu B, León L, Calderon DMS, Kiltz U. Walsh JA, et al. Among authors: zhu b. Arthritis Care Res (Hoboken). 2022 Mar;74(3):451-460. doi: 10.1002/acr.24482. Epub 2022 Jan 26. Arthritis Care Res (Hoboken). 2022. PMID: 33044756 Free PMC article. Clinical Trial.

6

Real-World Treatment Patterns and Healthcare Costs in Patients with Psoriatic Arthritis Treated with Ixekizumab: A Retrospective Study.

Murage MJ, Princic N, Park J, Malatestinic W, Zhu B, Atiya B, Kern SA, Stenger KB, Sprabery AT, Ogdie A. Murage MJ, et al. Among authors: zhu b. ACR Open Rheumatol. 2021 Dec;3(12):879-887. doi: 10.1002/acr2.11347. Epub 2021 Sep 22. ACR Open Rheumatol. 2021. PMID: 34550647 Free PMC article.

7

Ixekizumab Real-World Effectiveness at 24 Weeks in Patients with Psoriasis: Data from the United States Taltz Customer Support Program.

Gottlieb AB, Burge R, Malatestinic WN, Zhu B, Zhao Y, McCormack J, Kimel M, Merola JF. Gottlieb AB, et al. Among authors: zhu b. Dermatol Ther (Heidelb). 2023 Aug;13(8):1831-1846. doi: 10.1007/s13555-023-00969-1. Epub 2023 Jul 11. Dermatol Ther (Heidelb). 2023. PMID: 37434099 Free PMC article.

8

Early clinical response as a predictor of subsequent response to ixekizumab treatment: results from a phase II study of patients with moderate-to-severe plaque psoriasis.

Zhu B, Edson-Heredia E, Cameron GS, Shen W, Erickson J, Shrom D, Wang P, Banerjee S, Gordon KB. Zhu B, et al. Br J Dermatol. 2013 Dec;169(6):1337-41. doi: 10.1111/bjd.12610. Br J Dermatol. 2013. PMID: 24032554 Clinical Trial.

9

Effect of Ixekizumab Treatment on Work Productivity for Patients With Moderate-to-Severe Plaque Psoriasis: Analysis of Results From 3 Randomized Phase 3 Clinical Trials.

Armstrong AW, Lynde CW, McBride SR, Ståhle M, Edson-Heredia E, Zhu B, Amato D, Nikaï E, Yang FE, Gordon KB. Armstrong AW, et al. Among authors: zhu b. JAMA Dermatol. 2016 Jun 1;152(6):661-9. doi: 10.1001/jamadermatol.2016.0269. JAMA Dermatol. 2016. PMID: 26953848

10

Impact of ixekizumab on psoriasis itch severity and other psoriasis symptoms: Results from 3 phase III psoriasis clinical trials.

Kimball AB, Luger T, Gottlieb A, Puig L, Kaufmann R, Nikaï E, Zhu B, Edson-Heredia E, Carlier H, Lin CY, Goldblum O, Yosipovitch G. Kimball AB, et al. Among authors: zhu b. J Am Acad Dermatol. 2016 Dec;75(6):1156-1161. doi: 10.1016/j.jaad.2016.07.034. Epub 2016 Sep 27. J Am Acad Dermatol. 2016. PMID: 27692498 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,169 results

Search Page

Filters